摘要
阵发性室上性心动过速(PSVT)是临床上一种较常见的快速性心律失常,任何年龄均可发病,可见于冠心病、风湿性心脏病、心肌病,高血压病、预激综合征等患者,也可见于无器质性心脏病的人,多数患者有反复发作的病史。本文收集我院1983年以来部分用异搏定治疗的PSVT患者42例,并与同期用西地兰治疗的42例PSVT患者作回顾性对比分析。
42 patients with paroxysmal supraventricular tachycardia were treated with intravenous verapamil and compared with the control group treated by intravenous cedilanid. The clinical results of verapamil group showed that verapamil had the following advantages over cedilanid: (1) The total effective rate of verapamil group (90.47%) is much higher than cedilanid group (64.29%) (P<0.01). (2) The disease responded to verapamil more rapidly (mean5.75±6.42 min than to cedilanid (mean 34.88±22.90min) (P<0.01). Therefore we recommend the use of verapamil as the drug of first choice for terminating paroxysmal supraventricular tachycardia with narrow QRS complexes.
出处
《宁夏医学杂志》
CAS
1990年第4期210-211,206,共3页
Ningxia Medical Journal
